References
- Hanson U, Persson B. Epidemiology of pregnancy‐induced hypertension and preeclampsia in type 1 (insulin‐dependent) diabetic pregnancies in Sweden. Acta Obstet Gynecol Scand 1998; 77: 620–624
- Gamer P R. Type 1 diabetes mellitus and pregnancy. Lancet 1995; 346: 152–161
- Greene M F, Hare J W, Krache M, Phillipe M, Barss V A, Saltzman D H, Nadel A, Younger M D, Heffner L, Scherl J E. Prematurity among insulin‐requiring diabetic gravid women. Am J Obstet Gynecol 1989; 161: 106–111
- Siddiqi T, Rosenn B, Mimouni F, Khoury J, Miodovnik M. Hypertension during pregnancy in insulin‐dependent diabetic women. Obstet Gynecol 1991; 77: 514–519
- Combs C A, Rosenn B, Kitzmiller J L, Khoury J C, Wheeler B C, Miodovnik M. Early‐pregnancy proteinuria in diabetes related to preeclampsia. Obstet Gynecol 1993; 82: 802–807
- Gordon M, Landon M B, Samuels P, Hissrich S, Gabbe S G. Perinatal outcome and long‐term follow‐up associated with modem management of diabetic nephropathy. Obstet Gynecol 1996; 87: 401–409
- Reece E A, Coustan D R, Hayslett J P, Holford T, Coulehan J, O'Conor T Z, et al. Diabetic nephropathy: pregnancy performance and fetomatemal outcome. Am J Obstet Gynecol 1988; 159: 56–66
- Hanson U, Persson B. Outcome of pregnancies complicated by type 1 insulin‐dependent diabetes in Sweden: acute pregnancy complications, neonatal mortality and morbidity. Am J Perinatol 1993; 10: 330–333
- Diamond M P, Shah D M, Hester R A, Vaughn W K, Cotton R B, Boehm F H. Complication of insulin‐dependent diabetic pregnancies by pre‐eclampsia and/or chronic hypertension: analysis of outcome. Am J Perinatol 1985; 2: 263–267
- Sibai B M, Lindheimer M L, Hauth J, Caritis S, VanDorsten P, Klebanoff M, MacPherson C, Landon M, Miodovnik M, Paul R, Meis P. Risk factors for preeclampsia, abruptio placentae, and adverse neonatal outcomes among women with chronic hypertension. N Engl J Med 1998; 339: 667471
- Caritis S, Sibai B, Hauth J, Lindheimer M D, Klebanoff M, Thom E, et al. Low‐dose aspirin to prevent preeclampsia in women at high risk. N Engl J Med 1998; 338: 701–705
- CLASP Collaborative Group. A randomized trial of low‐dose aspirin for the prevention and treatment of pre‐eclampsia among 9368 pregnancy women. Lancet 1994; 343: 619–629
- Gamer P R, D'Alton M E, Dudley D K, Huard P, Hardie M. Preeclampsia in diabetic pregnancies. Am J Obstet Gynecol 1990; 163: 505–508
- Miodovnik M, Rosenn B M, Khoury J C, Grigsley J L. Does pregnancy increase the risk for development and progression of diabetic nephropathy?. Am J Obstet Gynecol 1996; 174: 1180–1191
- Kovilam O, Rosenn B, Miodovnik M, Khoury J, et al. Is proliferative retinopathy a risk factor for adverse pregnancy outcome in women with Type I diabetes?. J Soc Gynecol Invest 1997; 4(1)152A, (Suppl.) Jan/Feb, Abstract #A291
- Sibai B M. Risk factors for preeclampsia and adverse neonatal outcome in women with preexisting diabetes mellitus. Am J Obstet Gynecol (SMFM Ed.) 1999, Abstract #77
- Caritis S, Sibai B, Hauth J, Lindheimer M, VanDorsten P, Klebanoff M, Elizabeth T, Vandersten P, Landon M. Predictors of preeclampsia in women at high risk. National Institution of Child Health and Human Development Network of Maternal‐Fetal Medicine Units. Am J Obstet Gynecol 1998; 179: 946–951
- Ekbom P, The Copenhagen Preeclampsia in Diabetic Pregnancy Study Group. Pre‐pregnancy microalbuminuria predicts pre‐eclampsia in insulin‐dependent diabetes mellitus. Lancet 1999; 353: 377
- Easterling J R, Brateng D, Schmucker B, Brown Z, Millard S P. Prevention of preeclampsia: a randomized trial of atenolol in hyperdynamic patients before onset of hypertension. Obstet Gynecol 1999; 93: 725–733